Article

RETRACTED: Sequential RAS mutations evaluation in cell-free DNA of patients with tissue RAS wild- type metastatic colorectal cancer: The PERSEIDA (Cohort 2) Study

2023-10-06

Abstract excerpt

<title>Abstract</title> <p>The authors have requested that this preprint be removed from Research Square.</p>

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 5877c686-4d7f-500b-bc63-51459f4a136c
DOI: 10.21203/rs.3.rs-3326762/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

RETRACTED: Sequential RAS mutations evaluation in cell-free DNA of patients with tissue RAS wild- type metastatic colorectal cancer: The PERSEIDA (Cohort 2) StudyDOI 10.21203/rs.3.rs-3326762/v1Read

Sequential RAS mutations evaluation in cell-free DNA of patients with tissue RAS wild-type metastatic colorectal cancer: the PERSEIDA (Cohort 2) study.Semantic proximity Read

Circulating Tumor DNA: The Dawn of a New Era in the Optimization of Chemotherapeutic Strategies for Metastatic Colo-Rectal Cancer Focusing on RAS MutationSemantic proximity Read

RAS mutations that have a major impact on current cancer genomic medicineSemantic proximity Read

Genomic landscape and survival analysis of ctDNA “neo-RAS wild-type” patients with originally RAS mutant metastatic colorectal cancerSemantic proximity Read

Next-Generation Sequencing of Circulating Tumor DNA Can Optimize Second-Line Treatment in RAS Wild-Type Metastatic Colorectal Cancer after Progression on anti-EGFR Therapy: Time to Rethink Our Approach.Semantic proximity Read

ASO Author Reflections: Impact of RAS Mutations on Total Neoadjuvant Therapy Outcomes in Rectal Cancer.Semantic proximity Read

Progress and potential of RAS mutation detection for diagnostics and companion diagnostics.Semantic proximity Read

Quantitative ctDNA Profiling of RAS Mutations as a Prognostic Biomarker in Metastatic Colorectal CancerSemantic proximity Read

The emergence of RAS mutations in patients with RAS wild-type mCRC receiving cetuximab as first-line treatment: a noninterventional, uncontrolled multicenter study.Semantic proximity Read

New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS?Semantic proximity Read

Effect of sex differences on the emergence of ctDNA RAS mutations in RAS wild-type colorectal cancer.Semantic proximity Read

Ras in digestive oncology: from molecular biology to clinical implications.Semantic proximity Read